85 related articles for article (PubMed ID: 3955401)
1. [Preclinical study of the pharmacodynamic and toxicologic effects of the antiarrhythmic agent, mexiletine].
Jezek L; Urbánková G; Gasparík J; Hudcovicová E; Nosál R; Hesek D; Rybár A; Mahrla Z
Bratisl Lek Listy; 1986 Feb; 85(2):152-9. PubMed ID: 3955401
[No Abstract] [Full Text] [Related]
2. Inhibition of sympathetic nervous system by mexiletine, an antiarrhythmic agent, and its antagonism against ouabain.
Kitagawa H; Takeda F; Kohei H
Arzneimittelforschung; 1985; 35(1A):356-9. PubMed ID: 4039173
[TBL] [Abstract][Full Text] [Related]
3. Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias.
Chew CY; Collett J; Singh BN
Drugs; 1979 Mar; 17(3):161-81. PubMed ID: 378646
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.
Carmeliet E
Acta Cardiol Suppl; 1980; (25):5-25. PubMed ID: 6246694
[No Abstract] [Full Text] [Related]
5. Pharmacological investigation of a new anti-arrhythmic agent, GYKI-23 107.
Varró A; Rabloczky G; Jaszlits L; Kürthy M; Zubovics Z; Toldy L
Drugs Exp Clin Res; 1987; 13(1):21-8. PubMed ID: 3595441
[TBL] [Abstract][Full Text] [Related]
6. [Hemodynamic effects of a new anti-arrhythmia agent: mexiletine].
Tomassetti V; Fontana F; Masi M; Mezzetti A; Poggiopollini G; Cuppini A; Cuccurullo F
Boll Soc Ital Cardiol; 1980; 25(1):95-100. PubMed ID: 7236434
[No Abstract] [Full Text] [Related]
7. Electrophysiologic effects of mexiletine on normal and ischemic ventricles.
Yoon MS; Han J
J Electrocardiol; 1982 Apr; 15(2):109-13. PubMed ID: 7069325
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological mechanisms for the antiarrhythmic action of mexiletine on digitalis-, reperfusion- and reoxygenation-induced arrhythmias.
Amerini S; Carbonin P; Cerbai E; Giotti A; Mugelli A; Pahor M
Br J Pharmacol; 1985 Dec; 86(4):805-15. PubMed ID: 4075017
[TBL] [Abstract][Full Text] [Related]
9. [Mexiletine, a drug with anti-arrhythmic action. Experimental research on the cardiovascular system].
Caputi AP; Rossi F; Lampa E; Imperatore A; Visone C; Marmo E
Arch Sci Med (Torino); 1979; 136(1):1-15. PubMed ID: 464786
[TBL] [Abstract][Full Text] [Related]
10. [The anti-arrhythmic action of mexiletine: experimental study].
Ciraolo O; Quartarone M; Corica F; D'Andrea Petrelli L; Barbera N; Ceruso D
G Clin Med; 1983 Nov; 64(11):483-90. PubMed ID: 6667804
[No Abstract] [Full Text] [Related]
11. [The effect of the new antiarrhythmic drug mexiletine on sinus node and intracardiac conduction in man (author's transl)].
Seipel L; Breithardt G; Schoerner U
Z Kardiol; 1978 Nov; 67(11):766-70. PubMed ID: 726555
[No Abstract] [Full Text] [Related]
12. Haemodynamic effects of a new anti-arrhythmic agent, mexiletine (Kö 1173) in ischaemic heart disease.
Saunamäki
Cardiovasc Res; 1975 Nov; 9(6):788-92. PubMed ID: 1203917
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic studies on mexiletine, anew antiarrhythmic agent.
Pozenel H
Postgrad Med J; 1977; 53 Suppl 1():78-80. PubMed ID: 69298
[No Abstract] [Full Text] [Related]
14. [Experimental studies on the antiarrhythmic mechanism of mexiletine in guinea pig ventricular muscles using microelectrode techniques].
Matsuo S
Nihon Ika Daigaku Zasshi; 1984 Apr; 51(2):208-23. PubMed ID: 6330160
[No Abstract] [Full Text] [Related]
15. Carbamate analogues of tocainide.
Cernusková L; Benes L; Csöllei J; Tumová I; Svec P
Pharmazie; 1994 Sep; 49(9):646-9. PubMed ID: 7526407
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological effects of mexiletine (Kö1173) on ovine cardiac Purkinje fibers.
Weld FM; Bigger JT; Swistel D; Bordiuk J; Lau YH
J Pharmacol Exp Ther; 1979 Aug; 210(2):222-8. PubMed ID: 458628
[TBL] [Abstract][Full Text] [Related]
17. Possible adverse effects on the cardiovascular system of an antiarrhythmic drug mexiletine.
Rossi F; Ruggiero E; Scafuro MA; Giasi M; Mazzeo V; Bile G; Lamparelli E; Marmo E
Arch Toxicol Suppl; 1984; 7():510-4. PubMed ID: 6596024
[TBL] [Abstract][Full Text] [Related]
18. [Hemodynamic and electrophysiological effects of intravenous injection of mexiletine].
Tanaka T; Kusumoto M; Umemura J; Miyazawa Y; Suwa J; Komatsu Y
Kokyu To Junkan; 1983 Dec; 31(12):1355-60. PubMed ID: 6676806
[No Abstract] [Full Text] [Related]
19. Antiarrhythmic and cardiovascular profiles of the fused indole compound (3aR,12R,12aR,12bS)-12-amino-2,3,3a,4,11,12,12a,12b-octahydro-10-hydrox yisoquino [2,1,8-lma]carbazol-5(1H)-one hydrochloride 1.5 hydrate.
Yorikane R; Mizuno H; Itoh Y; Koike H; Miyake S; Shiga H; Kumakura S; Fukami M; Shimoji Y; Hashimoto T
Arzneimittelforschung; 1991 Nov; 41(11):1130-6. PubMed ID: 1810258
[TBL] [Abstract][Full Text] [Related]
20. [Mexitil (Mexiletine). A new antiarrhythmic agent].
Bjerregaard P
Ugeskr Laeger; 1980 Oct; 142(43):2855-6. PubMed ID: 7445202
[No Abstract] [Full Text] [Related]
[Next] [New Search]
